Mr. Hobbs is currently Chairman of the Board at ZyCal Bioceuticals and a principal of Parametrics Medical, LLC, as well as a Managing Partner at Graylyn Associates, Inc. Mr. Hobbs’ thirty years of executive management experience includes CEO of Endospine Kinetics (acquired), CEO of Luxtec Corp. (acquired) and CEO of Genica Pharmaceuticals (acquired). Additionally, Mr. Hobbs served as President of Johnson & Johnson Professional Diagnostics, a division of J&J.
Mr. Scaffidi founded ZyCal in February 2006 after working in the healthcare industry for nearly 20 years. Mr. Scaffidi received his BS degree from City University of New York in Biochemistry and completed three years of research in enzymology and protein purification.
Dr. Tripodi holds a PhD in Immunochemistry from Temple University. He has published extensively in the fields of immunochemistry and immunology, and holds several patents, for both drugs and devices. Most of Dr. Tripodi’s industrial career was with Johnson & Johnson for more than 20 years.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.